Blocking ROS production with NAC and DPI, but not Mito-TEMPO, completely inhibited LC3-II conversion (Fig 4C), suggesting that the ROS production, presumably through a NOX family of NADPH oxidase, is required for triggering autophagy in brazilin-treated RA FLS. The gene discussed is FMO5; the disease is rheumatoid arthritis.